ArticleNorthern clinics of Istanbul2025

Impact of progression sites and line of therapy on survival outcomes in patients with HER-2 positive metastatic breast cancer treated with T-DM1.

Heves Surmeli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.